Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 735292, 9 pages
http://dx.doi.org/10.1155/2014/735292
Research Article

Epigenetic Alterations of Chromosome 3 Revealed by NotI-Microarrays in Clear Cell Renal Cell Carcinoma

1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow 119991, Russia
2P.A. Herzen Moscow Oncology Research Institute, Ministry of Healthcare of the Russian Federation, Moscow 125284, Russia
3Institute of Molecular Biology and Genetics, Ukrainian Academy of Sciences, Kiev 03680, Ukraine
4Mechnikov Research Institute for Vaccines and Sera, Russian Academy of Medical Sciences, Moscow 105064, Russia
5National Cancer Institute, Kiev 03022, Ukraine
6N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow 115478, Russia
7Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow 125315, Russia
8Research Center of Medical Genetics, Russian Academy of Medical Sciences, Moscow 115478, Russia
9Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, 17177 Stockholm, Sweden

Received 19 February 2014; Revised 10 April 2014; Accepted 17 April 2014; Published 22 May 2014

Academic Editor: Carole Sourbier

Copyright © 2014 Alexey A. Dmitriev et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [21 citations]

The following is the list of published articles that have cited the current article.

  • E. E. Rudenko, G. V. Gerashchenko, Y. V. Lapska, S. O. Vozianov, Y. M. Zgonnyk, and V. I. Kashuba, “PPM1M and PRICKLE2 are potential tumor suppressor genes in human clear-cell renal cell carcinoma,” Biopolymers and Cell, vol. 30, no. 3, pp. 229–233, 2014. View at Publisher · View at Google Scholar
  • M. S. Fedorova, A. V. Kudryavtseva, V. A. Lakunina, A. V. Snezhkina, N. N. Volchenko, E. N. Slavnova, T. V. Danilova, A. F. Sadritdinova, N. V. Melnikova, A. A. Belova, K. M. Klimina, D. V. Sidorov, B. Ya. Alekseev, A. D. Kaprin, A. A. Dmitriev, and G. S. Krasnov, “Downregulation of OGDHL expression is associated with promoter hypermethylation in colorectal cancer,” Molecular Biology, vol. 49, no. 4, pp. 608–617, 2015. View at Publisher · View at Google Scholar
  • E. A. Braga, D. S. Khodyrev, V. I. Loginov, I. V. Pronina, V. N. Senchenko, A. A. Dmitriev, A. A. Kubatiev, and N. E. Kushlinskii, “Methylation in the regulation of the expression of chromosome 3 and microRNA genes in clear-cell renal cell carcinomas,” Russian Journal Of Genetics, vol. 51, no. 6, pp. 566–581, 2015. View at Publisher · View at Google Scholar
  • E. E. Rudenko, Y. V. Lapska, G. V. Gerashchenko, E. O. Stakhovsky, M. V. Vikarchuk, and V. I. Kashuba, “Heterozygous deletions are main cause of expression alterations of PPM1M and PRICLE2 genes in human clear cell renal cell carcinomas,” Biopolymers and Cell, vol. 31, no. 1, pp. 29–33, 2015. View at Publisher · View at Google Scholar
  • Vinothini Govindarajah, Yuet-Kin Leung, Jun Ying, Robin Gear, Robert L. Bornschein, Mario Medvedovic, and Shuk-Mei Ho, “In utero exposure of rats to high-fat diets perturbs gene-expression profiles and cancer susceptibility of prepubertal mammary glands,” The Journal of Nutritional Biochemistry, 2015. View at Publisher · View at Google Scholar
  • Nadezda Petejova, and Arnost Martinek, “Renal cell carcinoma: review of etiology, pathophysiology and risk factors,” Biomedical Papers, 2015. View at Publisher · View at Google Scholar
  • Irina V. Pronina, Vitaly I. Loginov, Alexey M. Burdennyy, Marina V. Fridman, Tatiana P. Kazubskaya, Alexey A. Dmitriev, and Eleonora A. Braga, “Expression and DNA methylation alterations of seven cancer-associated 3p genes and their predicted regulator miRNAs (miR-129-2, miR-9-1) in breast and ovarian cancers,” Gene, 2015. View at Publisher · View at Google Scholar
  • Alexey A. Dmitriev, Eugenia E. Rosenberg, George S. Krasnov, Ganna V. Gerashchenko, Vasily V. Gordiyuk, Tatiana V. Pavlova, Anna V. Kudryavtseva, Artemy D. Beniaminov, Anastasia A. Belova, Yuriy N. Bondarenko, Rostislav O. Danilets, Alexander I. Glukhov, Aleksandr G. Kondratov, Andrey Alexeyenko, Boris Y. Alekseev, George Klein, Vera N. Senchenko, and Vladimir I. Kashuba, “Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis,” Disease Markers, vol. 2015, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Katarzyna Kluzek, Hans A Bluyssen, and Joanna Wesoly, “The epigenetic landscape of clear-cell renal cell carcinoma.,” Journal of kidney cancer and VHL, vol. 2, no. 3, pp. 90–104, 2015. View at Publisher · View at Google Scholar
  • Chunbo Zhuang, Pei Wang, Da Huang, Luming Xu, Xiaobei Wang, Lin Wang, and Lihua Hu, “A double-negative feedback loop between EZH2 and miR-26a regulates tumor cell growth in hepatocellular carcinoma,” International Journal Of Oncology, vol. 48, no. 3, pp. 1195–1204, 2016. View at Publisher · View at Google Scholar
  • Ziyi Zhao, Shasha Zhao, Chen Chen, Xiaofeng Cong, Meng Ren, Lei Yang, and Zhi Li, “The Clinicopathological Significance of Epigenetic Silencing of VHL Promoter and Renal Cell Carcinoma: A Meta-Analysis,” Cellular Physiology and Biochemistry, vol. 40, no. 6, pp. 1465–1472, 2016. View at Publisher · View at Google Scholar
  • Zhengtao Liu, Huang Ketuan, Lequn Li, Xue Qin, Xiaoguang Liu, Wei Qin, Hao Su, Zhiwei Chen, Guangzhi Zhu, Yu Liang, Huang Jianlu, Tingdong Yu, Chengkun Yang, Shang Liming, Xinping Ye, Xiwen Liao, Kaiyin Xiao, Peng Minhao, Peng Tao, Chuangye Han, Long Yu, and Sicong Lu, “ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma,” Oncology Reports, vol. 38, no. 3, pp. 1451–1463, 2017. View at Publisher · View at Google Scholar
  • Johan Heldin, Paul O'Callaghan, Rodrigo Hernández Vera, Peder Fredlund Fuchs, Pär Gerwins, and Johan Kreuger, “FGD5 sustains vascular endothelial growth factor A (VEGFA) signaling through inhibition of proteasome-mediated VEGF receptor 2 degradation,” Cellular Signalling, 2017. View at Publisher · View at Google Scholar
  • I. V. Pronina, E. A. Klimov, A. M. Burdennyy, E. V. Beresneva, M. V. Fridman, V. D. Ermilova, T. P. Kazubskaya, A. V. Karpukhin, E. A. Braga, and V. I. Loginov, “Methylation of the genes for the microRNAs miR-129-2 and miR-9-1, changes in their expression, and activation of their potential target genes in clear cell renal cell carcinoma,” Molecular Biology, vol. 51, no. 1, pp. 61–71, 2017. View at Publisher · View at Google Scholar
  • Marit Valla, Monica Jernberg Engstrøm, Borgny Ytterhus, Åse Kristin Skain Hansen, Lars Andreas Akslen, Lars Johan Vatten, Signe Opdahl, and Anna Mary Bofin, “FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis,” Breast Cancer Research and Treatment, vol. 162, no. 2, pp. 243–253, 2017. View at Publisher · View at Google Scholar
  • Krasnov, Beniaminov, Puzanov, Kudryavtseva, Dmitriev, Tychko, and Novakovskiy, “Promising markers of CIMP+ colon tumors identified on the basis of TCGA data analysis,” Vavilovskii Zhurnal Genetiki i Selektsii, vol. 21, no. 8, pp. 920–924, 2017. View at Publisher · View at Google Scholar
  • Qasim A. Khan, Peter Pediaditakis, Yuryi Malakhau, Amin Esmaeilniakooshkghazi, Zahra Ashkavand, Valentin Sereda, Natalia I. Krupenko, and Sergey A. Krupenko, “CHIP E3 ligase mediates proteasomal degradation of the proliferation regulatory protein ALDH1L1 during the transition of NIH3T3 fibroblasts from G0/G1 to S-phase,” Plos One, vol. 13, no. 7, pp. e0199699, 2018. View at Publisher · View at Google Scholar
  • A. V. Snezhkina, K. M. Nyushko, A. R. Zaretsky, D. A. Shagin, A. F. Sadritdinova, M. S. Fedorova, Z. G. Guvatova, I. S. Abramov, E. A. Pudova, B. Y. Alekseev, A. A. Dmitriev, and A. V. Kudryavtseva, “Transcription Factor SAP30 Is Involved in the Activation of NETO2 Gene Expression in Clear Cell Renal Cell Carcinoma,” Molecular Biology, vol. 52, no. 3, pp. 385–392, 2018. View at Publisher · View at Google Scholar
  • A. V. Kudryavtseva, K. M. Nyushko, A. R. Zaretsky, D. A. Shagin, A. F. Sadritdinova, M. S. Fedorova, M. V. Savvateeva, Z. G. Guvatova, E. A. Pudova, B. Y. Alekseev, A. A. Dmitriev, and A. V. Snezhkina, “Suppression of NR0B2 gene in Clear Cell Renal Cell Carcinoma Is Associated with Hypermethylation of Its Promoter,” Molecular Biology, vol. 52, no. 3, pp. 414–418, 2018. View at Publisher · View at Google Scholar
  • Artemy D. Beniaminov, Grigory A. Puzanov, George S. Krasnov, Dmitry N. Kaluzhny, Tatiana P. Kazubskaya, Eleonora A. Braga, Anna V. Kudryavtseva, Nataliya V. Melnikova, and Alexey A. Dmitriev, “Deep Sequencing Revealed a CpG Methylation Pattern Associated With ALDH1L1 Suppression in Breast Cancer,” Frontiers in Genetics, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Sergey A. Krupenko, and Natalia I. Krupenko, “ALDH1L1 and ALDH1L2 Folate Regulatory Enzymes in Cancer,” Alcohol and Cancer, vol. 1032, pp. 127–143, 2018. View at Publisher · View at Google Scholar